Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 5

Results: 23

Treatment horizon in multiple myeloma.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 425, doi. 10.1111/ejh.13840
By:
- Soekojo, Cinnie Yentia;
- Chng, Wee Joo
Publication type:
Article
Haematological changes from conception to childbirth: An indicator of major pregnancy complications.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 566, doi. 10.1111/ejh.13844
By:
- Patxot, Marion;
- Stojanov, Miloš;
- Ojavee, Sven Erik;
- Gobert, Rosanna Pescini;
- Kutalik, Zoltán;
- Gavillet, Mathilde;
- Baud, David;
- Robinson, Matthew R.
Publication type:
Article
Palliative care utilization, transfusion burden, and end‐of‐life care for patients with multiple myeloma.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 559, doi. 10.1111/ejh.13843
By:
- McInturf, Geoffrey;
- Younger, Kimberly;
- Sanchez, Courtney;
- Walde, Charles;
- Abdallah, Al‐Ola;
- Ahmed, Nausheen;
- Shune, Leyla;
- Sborov, Douglas W.;
- Godara, Amandeep;
- McClune, Brian;
- Sinclair, Christian T.;
- Mohyuddin, Ghulam Rehman
Publication type:
Article
Idiopathic upper extremity deep vein thrombosis: A systematic review.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 542, doi. 10.1111/ejh.13842
By:
- Yuen, Hiu Lam Agnes;
- Tan, Ee;
- Tran, Huyen;
- Chunilal, Sanjeev Daya
Publication type:
Article
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 526, doi. 10.1111/ejh.13841
By:
- Christensen, Sarah Friis;
- Svingel, Lise Skovgaard;
- Kjærsgaard, Anders;
- Stenling, Anna;
- Darvalics, Bianka;
- Paulsson, Björn;
- Andersen, Christen Lykkegaard;
- Christiansen, Christian Fynbo;
- Stentoft, Jesper;
- Starklint, Jørn;
- Severinsen, Marianne Tang;
- Clausen, Mette Borg;
- Hilsøe, Morten Hagemann;
- Hasselbalch, Hans Carl;
- Frederiksen, Henrik;
- Mikkelsen, Ellen Margrethe;
- Bak, Marie
Publication type:
Article
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 576, doi. 10.1111/ejh.13845
By:
- Larsen, Morten K.;
- Skov, Vibe;
- Kjær, Lasse;
- Møller‐Palacino, Natascha A.;
- Pedersen, Rasmus K.;
- Andersen, Morten;
- Ottesen, Johnny T.;
- Cordua, Sabrina;
- Poulsen, Henrik E.;
- Dahl, Morten;
- Knudsen, Trine A.;
- Eickhardt‐Dalbøge, Christina Schjellerup;
- Koschmieder, Steffen;
- Pedersen, Kasper M.;
- Çolak, Yunus;
- Bojesen, Stig E.;
- Nordestgaard, Børge G.;
- Stiehl, Thomas;
- Hasselbalch, Hans C.;
- Ellervik, Christina
Publication type:
Article
The evolution of immune dysfunction in multiple myeloma.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 415, doi. 10.1111/ejh.13839
By:
- Soekojo, Cinnie Yentia;
- Chng, Wee Joo
Publication type:
Article
Association of iron infusion reactions with ABO blood type.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 519, doi. 10.1111/ejh.13838
By:
- Butt, Ayesha;
- Muradashvili, Tinatin;
- Soliman, Sara;
- Li, Fangyong;
- Burns, Adrienne J.;
- Brooks, Andrea;
- Browning, Sabrina;
- Bar, Noffar;
- Borgman, Gena;
- Goshua, George;
- Hwa, John;
- Martin, Kelsey;
- Rinder, Henry;
- Tormey, Christopher;
- Pine, Alexander B.;
- Bona, Robert D.;
- Lee, Alfred I.;
- Neparidze, Natalia
Publication type:
Article
Venetoclax induces deep and durable minimal residual disease‐negative remission in high‐risk TP53 disrupted B prolymphocytic leukaemia.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 590, doi. 10.1111/ejh.13837
By:
- Chen, Lucia Y.;
- Eyre, Toby A.
Publication type:
Article
Loss of LEF‐1 expression as a diagnostic indicator for extranodal NK/T‐cell lymphoma: An immunohistochemical study of 88 cases.
Published in:
2022
By:
- Qiu, Cen;
- Du, Guangye
Publication type:
Case Study
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 504, doi. 10.1111/ejh.13835
By:
- Spicka, Ivan;
- Moreau, Philippe;
- Martin, Thomas G.;
- Facon, Thierry;
- Martinez, Gracia;
- Oriol, Albert;
- Koh, Youngil;
- Lim, Andrew;
- Mikala, Gabor;
- Rosiñol, Laura;
- Yağci, Münci;
- Cavo, Michele;
- Risse, Marie‐Laure;
- Asset, Gaëlle;
- Macé, Sandrine;
- van de Velde, Helgi;
- Yong, Kwee
Publication type:
Article
Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: A retrospective study.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 494, doi. 10.1111/ejh.13834
By:
- Al‐Ansari, Ameena Mohammed;
- Abd‐El‐Gawad, Wafaa Mostafa;
- AboSerea, Sobhi Mostafa;
- Ali, Ali Adli;
- Abdullah, Maha Mohammed;
- Ali, Fatma Abdel Shakor;
- ElShereafy, Eman El Sayed;
- Bahnasy, Mohamed Abd El Badie
Publication type:
Article
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 483, doi. 10.1111/ejh.13833
By:
- Giudice, Valentina;
- Serio, Bianca;
- Bertolini, Angela;
- Mettivier, Laura;
- D'Alto, Francesca;
- Pezzullo, Luca;
- D'Addona, Matteo;
- Fumo, Rosalba;
- Zeppa, Pio;
- Gorrese, Marisa;
- Selleri, Carmine
Publication type:
Article
Risk of multiple myeloma and other malignancies among first‐and second‐degree relatives of patients with multiple myeloma: A population‐based study.
Published in:
2022
Publication type:
Correction Notice
Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the "RTL" (Regional TUSCAN Lymphoma Network)—Authors' reply to Morris and colleagues.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 595, doi. 10.1111/ejh.13831
By:
- Cencini, Emanuele;
- Fabbri, Alberto
Publication type:
Article
Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe.
Published in:
2022
By:
- Ferlis, Mica;
- Lipato, Thokozeni;
- Roseff, Susan D.;
- Smith, Wally R.
Publication type:
Case Study
Pixantrone as a bridge to CAR‐T treatment in high‐grade transformation of follicular lymphoma.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 593, doi. 10.1111/ejh.13829
By:
- Morris, Joseph;
- O'Reilly, Maeve;
- Sargent, Jeremy;
- Murphy, Philip;
- Glavey, Siobhan;
- Quinn, John
Publication type:
Article
A retrospective study of treosulfan versus busulfan‐based conditioning in pediatric patients.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 474, doi. 10.1111/ejh.13828
By:
- Olivas‐Mazón, Raquel;
- Bueno, David;
- Sisinni, Luisa;
- Mozo, Yasmina;
- Casado‐Abad, Gema;
- Martínez, Antonio Pérez
Publication type:
Article
Ten‐year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 465, doi. 10.1111/ejh.13827
By:
- Phan, Vivian;
- Park, Ju Ae;
- Dulman, Robin;
- Lewis, Angela;
- Briere, Noravy;
- Notarangelo, Bailey;
- Yang, Elizabeth
Publication type:
Article
Neutralizing antibody responses against SARS‐CoV‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 458, doi. 10.1111/ejh.13826
By:
- Abdallah, Al‐Ola;
- Mahmoudjafari, Zahra;
- Atieh, Tahani;
- Ahmed, Nausheen;
- Cui, Wei;
- Shune, Leyla;
- Mohan, Meera;
- McGuirk, Joseph;
- Remker, Cassie;
- Foss, Margaret;
- Karloff, Ellie;
- Fitch, Heather;
- Atrash, Shebli
Publication type:
Article
Busulfan and cyclophosphamide‐based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion‐dependent thalassemia, even in high risk.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 447, doi. 10.1111/ejh.13825
By:
- Mehta, Pallavi;
- Kapoor, Jyotsna;
- Singh, Aakanksha;
- Yadav, Neha;
- Singh, Reema;
- Halder, Rohan;
- Verma, Megha;
- Agrawal, Narendra;
- Ahmed, Rayaz;
- Bhurani, Dinesh
Publication type:
Article
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 441, doi. 10.1111/ejh.13824
By:
- Elizabeth, Smyth;
- Aidan, Kelly;
- David, O' Brien;
- Deirdre, Waldron;
- Sarah, Brophy;
- Emer, Atkinson;
- Kanthi, Perera;
- Crotty, Gerard M.;
- Aileen, Walsh;
- Michelle, Connolly;
- Ruth, Clifford;
- Hilary, O'Leary;
- Ashique, Khan;
- Bacon, Christopher L.;
- Emily, Smyth;
- McElligott, Anthony M.;
- Fiona, Quinn;
- Elisabeth, Vandenberghe;
- Carmel, Waldron
Publication type:
Article
Issue Information.
Published in:
European Journal of Haematology, 2022, v. 109, n. 5, p. 413, doi. 10.1111/ejh.13661
Publication type:
Article